 | Up a level |
2021
Galldiks, Norbert, Abdulla, Diana S. Y., Scheffler, Matthias, Wolpert, Fabian, Werner, Jan-Michael 
ORCID: 0000-0001-7147-4594, Huellner, Martin, Stoffels, Gabriele, Schweinsberg, Viola, Schlaak, Max, Kreuzberg, Nicole, Landsberg, Jennifer, Lohmann, Philipp ORCID: 0000-0002-5360-046X, Ceccon, Garry, Baues, Christian, Trommer, Maike, Celik, Eren, Ruge, Maximilian, I, Kocher, Martin, Marnitz, Simone, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Tonn, Joerg-Christian, Weller, Michael, Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Wolf, Juergen and Mauch, Cornelia
(2021).
Treatment Monitoring of Immunotherapy and Targeted Therapy Using F-18-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences.
J. Nucl. Med., 62 (4).
S. 464 - 471.
RESTON:
SOC NUCLEAR MEDICINE INC.
ISSN 1535-5667
Kron, Anna, Scheffler, Matthias, Heydt, Carina, Ruge, Lea, Schaepers, Carsten, Eisert, Anna-Kristina, Merkelbach-Bruse, Sabine, Riedel, Richard, Nogova, Lucia, Fischer, Rieke Nila, Michels, Sebastian, Abdulla, Diana S. Y., Koleczko, Sophia, Fassunke, Jana, Schultheis, Anne M., Kron, Florian, Ueckeroth, Frank, Wessling, Gabriele, Sueptitz, Juliane, Beckers, Frank, Braess, Jan, Panse, Jens, Grohe, Christian, Hamm, Michael, Kabitz, Hans-Joachim, Kambartel, Kato, Kaminsky, Britta, Krueger, Stefan, Schulte, Clemens, Lorenz, Joachim, Lorenzen, Johann, Meister, Wolfram, Meyer, Andreas, Kappes, Jutta, Reinmuth, Niels, Schaaf, Bernhard, Schulte, Wolfgang, Serke, Monika, Buettner, Reinhard and Wolf, Juergen (2021). Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy. J. Thorac. Oncol., 16 (4). S. 572 - 583. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
2020
Nogova, Lucia, Mattonet, Christian, Scheffler, Matthias ORCID: 0000-0002-9031-1368, Taubert, Max ORCID: 0000-0001-8925-7782, Gardizi, Masyar, Sos, Martin L., Michels, Sebastian, Fischer, Rieke N., Limburg, Meike, Abdulla, Diana S. Y., Persigehl, Thorsten, Kobe, Carsten, Merkelbach-Bruse, Sabine, Franklin, Jeremy, Backes, Heiko, Schnell, Roland, Behringer, Dirk, Kaminsky, Britta, Eichstaedt, Martina, Stelzer, Christoph, Kinzig, Martina, Soergel, Fritz, Tian, Yingying, Junge, Lisa, Suleiman, Ahmed A., Frechen, Sebastian, Rokitta, Dennis, Ouyang, Dongsheng, Fuhr, Uwe, Buettner, Reinhard and Wolf, Juergen
(2020).
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment.
Cancer Med., 9 (14).
S. 4991 - 5008.
HOBOKEN:
WILEY.
ISSN 2045-7634
Scheffler, Matthias, Holzem, Alessandra, Kron, Anna, Nogova, Lucia, Ihle, Michaela A., von Levetzow, Cornelia, Fassunke, Jana, Woempner, Claudia, Bitter, Elisabeth, Koleczko, Sophia, Abdulla, Diana S. Y., Michels, Sebastian, Fischer, Rieke, Riedel, Richard, Weber, Jan-Philipp, Westphal, Theresa, Gerigk, Ulrich, Kern, Jens, Kaminsky, Britta, Randerath, Winfried, Kambartel, Karl-Otto, Merkelbach-Bruse, Sabine, Buttner, Reinhard and Wolf, Juergen (2020). Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations. Lung Cancer, 144. S. 40 - 49. CLARE: ELSEVIER IRELAND LTD. ISSN 1872-8332
2019
Abdulla, Diana S. Y., Scheffler, Matthias ORCID: 0000-0002-9031-1368, Brandes, Vanessa, Ruge, Maximilian, Kunze, Sabine, Merkelbach-Bruse, Sabine, Nogova, Lucia, Michels, Sebastian, Fischer, Rieke, Riedel, Richard, Buettner, Reinhard, Persigehl, Thorsten, Grau, Stefan, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Drzezga, Alexander ORCID: 0000-0001-6018-716X, Kobe, Carsten and Wolf, Juergen
(2019).
Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2[F-18]fluoroethyl)-L-tyrosine PET.
Clin. Lung Cancer, 20 (2).
S. E148 - 4.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 1938-0690
Michels, Sebastian, Massuti, Bartomeu, Schildhaus, Hans-Ulrich, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Sebastian, Martin, Felip, Enriqueta, Grohe, Christian, Rodriguez-Abreu, Delvys, Abdulla, Diana S. Y., Bischoff, Helge, Brandts, Christian, Carcereny, Enric, Corral, Jesus, Dingemans, Anne-Marie C., Pereira, Eva, Fassunke, Jana, Fischer, Rieke N., Gardizi, Masyar, Heukamp, Lukas ORCID: 0000-0002-3388-3482, Insa, Amelia, Kron, Anna, Menon, Roopika, Persigehl, Thorsten, Reck, Martin, Riedel, Richard, Rothschild, Sacha I., Scheel, Andreas H., Scheffler, Matthias, Schmalz, Petra, Smit, Egbert F., Limburg, Meike, Provencio, Mariano, Karachaliou, Niki, Merkelbach-Bruse, Sabine, Hellmich, Martin, Nogova, Lucia, Buettner, Reinhard, Rosell, Rafael and Wolf, Juergen
(2019).
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.
J. Thorac. Oncol., 14 (7).
S. 1266 - 1277.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
Riedel, Richard, Michels, Sebastian, Heydt, Carina, Siemanowski, Janna, Kobe, Carsten, Bunck, Anne, Schaefer, Stephan, Fischer, Rieke N., Scheffler, Matthias, Abdulla, Diana S. Y., Nogova, Lucia, Koleczko, Sophia, Merkelbach-Bruse, Sabine, Buettner, Reinhard and Wolf, Juergen (2019). Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma. Lung Cancer, 133. S. 20 - 23. CLARE: ELSEVIER IRELAND LTD. ISSN 1872-8332
Scheffler, Matthias, Ihle, Michaela A., Hein, Rebecca, Merkelbach-Bruse, Sabine, Scheel, Andreas H., Siemanowski, Janna, Braegelmann, Johannes, Kron, Anna, Abedpour, Nima, Ueckeroth, Frank, Schueller, Merle, Koleczko, Sophia, Michels, Sebastian, Fassunke, Jana, Pasternack, Helen, Heydt, Carina, Serke, Monika, Fischer, Rieke, Schulte, Wolfgang, Gerigk, Ulrich, Nogova, Lucia, Ko, Yon-Dschun, Abdulla, Diana S. Y., Riedel, Richard, Kambartel, Karl-Otto, Lorenz, Joachim, Sauerland, Imke, Randerath, Winfried, Kaminsky, Britta, Hagmeyer, Lars, Grohe, Christian, Eisert, Anna, Frank, Rieke, Gogl, Leonie, Schaepers, Carsten, Holzem, Alessandra, Hellmich, Martin, Thomas, Roman K., Peifer, Martin, Sos, Martin L., Buettner, Reinhard and Wolf, Juergen (2019). K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways. J. Thorac. Oncol., 14 (4). S. 606 - 617. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
2018
Michels, Sebastian, Scheffler, Matthias, Wagener, Svenja, Plenker, Dennis, Scheel, Andreas, Nogova, Lucia, Schultheis, Anne, Fischer, Rieke N., Abdulla, Diana S. Y., Riedel, Richard, Bunck, Anne, Kobe, Carsten, Baus, Wolfgang, Merkelbach-Bruse, Sabine, Sos, Martin L., Buttner, Reinhard and Wolf, Jurgen (2018). Loss of G2032R Resistance Mutation Upon Chemotherapy Treatment Enables Successful Crizotinib Rechallenge in a Patient With ROS1-Rearranged NSCLC. JCO Precis. Oncol., 2. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 2473-4284